Transform Pharmaceuticals, Inc.
Records under this name other than patents Transform Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Transform Pharmaceuticals, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,563,013 | Systems and Methods for Delivering a Fluid Drug now held by Janssen Biotech, Inc. In force · High confidence | In force | High confidence | |
| US 8,815,950 | Pharmaceutical Compositions and Method of Using Levodopa and Carbidopa now held by Janssen Biotech, Inc. Lapsed on the fee record Ended Aug 26, 2026 · High confidence | Lapsed on the fee record | Ended Aug 26, 2026 | High confidence |
| US 7,927,613 | Pharmaceutical Co-Crystal Compositions now held by Johnson & Johnson Consumer Inc. Term ended Ended no later than Sep 8, 2025 · Low confidence | Term ended | Ended no later than Sep 8, 2025 | Low confidence |
| US 7,205,413 | Solvates and Polymorphs of Ritonavir and Methods of Making and Using the Same now held by Centocor Ortho Biotech Inc. Term ended Term ended Apr 9, 2025 · High confidence | Term ended | Term ended Apr 9, 2025 | High confidence |
| US 8,367,656 | Polymorphs of 7-[(3-Chloro-6,11-Dihydro-6-Methyldibenzo[C,F][1,2]THIAZEPIN-11-YL)AMINO]HEPTANOIC Acid S,s Dioxide and Methods of Making and Using the Same now held by Janssen Biotech, Inc. Lapsed on the fee record Ended Feb 5, 2025 · High confidence | Lapsed on the fee record | Ended Feb 5, 2025 | High confidence |
| US 8,198,268 | Tianeptine Sulfate Salt Forms and Methods of Making and Using the Same now held by Janssen Biotech, Inc. Lapsed on the fee record Ended Jun 12, 2024 · High confidence | Lapsed on the fee record | Ended Jun 12, 2024 | High confidence |
| US 7,078,526 | Novel Cis-Itraconazole Crystalline Forms and Related Processes, Pharmaceutical Compositions and Methods Term ended Term ended Jan 29, 2024 · High confidence | Term ended | Term ended Jan 29, 2024 | High confidence |
| US 7,550,155 | Aqueous Pharmaceutical Compositions of 2,6-Diisopropylphenol (PROPOFOL) and Their Uses now held by Janssen Biotech, Inc. Term ended Term ended Jul 29, 2023 · High confidence | Term ended | Term ended Jul 29, 2023 | High confidence |
| US 7,915,317 | Aqueous 2,6-Diisopropylphenol Pharmaceutical Compositions now held by Janssen Biotech, Inc. Lapsed on the fee record Ended Mar 29, 2023 · High confidence | Lapsed on the fee record | Ended Mar 29, 2023 | High confidence |
| US 7,803,786 | Pharmaceutical Co-Crystal Compositions and Related Methods of Use now held by Janssen Biotech, Inc. Lapsed on the fee record Ended Sep 28, 2022 · High confidence | Lapsed on the fee record | Ended Sep 28, 2022 | High confidence |